Vycor Medical (VYCO) Current Assets (2010 - 2026)
Vycor Medical's (VYCO) quarterly Current Assets came in at $651047.0 in Q1 2026, up 8.38% year-on-year from $600695.0 in Q1 2025, and up 15.55% on a QoQ basis from $563422.0 in Q4 2025.
Vycor Medical (VYCO) Current Assets (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Current Assets data on file, last reported at $651047.0 in Q1 2026.
- On a quarterly basis, Current Assets rose 8.38% year-over-year to $651047.0 in Q1 2026; TTM through Mar 2026 was $651047.0, a 8.38% increase from a year earlier, with the FY2025 full-year figure at $563422.0, down 9.07% from the prior year.
- Current Assets for Q1 2026 stood at $651047.0, up from $563422.0 in the prior quarter.
- Over the last five years, Current Assets for VYCO reached as high as $743430.0 in Q3 2024 and fell as low as $512796.0 in Q2 2022.
- Historically, Current Assets has averaged $594053.5 across 5 years, with a median of $588180.0 in 2024.
- Across the five-year window, Current Assets grew 20.59% in 2023 and slipped 13.85% in 2025, its largest moves.
- Year by year, Current Assets stood at $517763.0 in 2022, then advanced by 12.81% to $584090.0 in 2023, then gained by 6.08% to $619614.0 in 2024, then decreased by 9.07% to $563422.0 in 2025, then gained by 15.55% to $651047.0 in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $651047.0 in Q1 2026, $563422.0 in Q4 2025, and $662596.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 4.33 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 11.45 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.43 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 4.10 Bn |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 651,047.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 651,047.00 |
| Dec 31, 2025 | 563,422.00 |
| Sep 30, 2025 | 662,596.00 |
| Jun 30, 2025 | 554,355.00 |
| Mar 31, 2025 | 600,695.00 |
| Dec 31, 2024 | 619,614.00 |
| Sep 30, 2024 | 743,430.00 |
| Jun 30, 2024 | 643,494.00 |
| Mar 31, 2024 | 588,180.00 |
| Dec 31, 2023 | 584,090.00 |
| Sep 30, 2023 | 625,888.00 |
| Jun 30, 2023 | 618,368.00 |
| Mar 31, 2023 | 520,494.00 |
| Dec 31, 2022 | 517,763.00 |
| Sep 30, 2022 | 579,794.00 |
| Jun 30, 2022 | 512,796.00 |
| Mar 31, 2022 | 512,884.00 |
| Dec 31, 2021 | 487,411.00 |
| Sep 30, 2021 | 562,219.00 |
| Jun 30, 2021 | 563,703.00 |